Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shintaro Kinugawa

Showing results (91-100 of 195) with videos related to

Pageof 20
Sort By:
Mitochondrion|July 22, 2019
A mitochondrial delivery system using liposome-based nanocarriers that target myoblast cellsTakashi Katayama, Shintaro Kinugawa, Shingo Takada, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|May 27, 2024
Esaxerenone: blood pressure reduction and cardiorenal protection without reflex sympathetic activation in salt-loaded stroke-prone spontaneously hypertensive ratsShota Ikeda, Keisuke Shinohara, Soichiro Kashihara, et al.
International Journal of Cardiology|June 15, 2010
Hyperuricemia predicts adverse outcomes in patients with heart failureSanae Hamaguchi, Tomoo Furumoto, Miyuki Tsuchihashi-Makaya, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|July 15, 2011
Lower aerobic capacity was associated with abnormal intramuscular energetics in patients with metabolic syndromeTakashi Yokota, Shintaro Kinugawa, Koichi Okita, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|December 5, 2009
Discharge use of angiotensin receptor blockers provides comparable effects with angiotensin-converting enzyme inhibitors on outcomes in patients hospitalized for heart failureMiyuki Tsuchihashi-Makaya, Tomoo Furumoto, Shintaro Kinugawa, et al.
American Heart Journal|December 15, 2010
Spironolactone use at discharge was associated with improved survival in hospitalized patients with systolic heart failureSanae Hamaguchi, Shintaro Kinugawa, Miyuki Tsuchihashi-Makaya, et al.
International Journal of Cardiology|April 19, 2011
Sex differences with respect to clinical characteristics, treatment, and long-term outcomes in patients with heart failureMiyuki Tsuchihashi-Makaya, Sanae Hamaguchi, Shintaro Kinugawa, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|November 10, 2010
Body mass index is an independent predictor of long-term outcomes in patients hospitalized with heart failure in JapanSanae Hamaguchi, Miyuki Tsuchihashi-Makaya, Shintaro Kinugawa, et al.
Life Sciences|April 3, 2020
Branched-chain amino acid supplementation ameliorates angiotensin II-induced skeletal muscle atrophyKatsuma Yamanashi, Shintaro Kinugawa, Arata Fukushima, et al.
Inflammation and Regeneration|March 10, 2026
Amphiregulin attenuates sepsis-induced myocardial dysfunction by maintaining the localization of connexin43Man Chen, Shinnosuke Takamori, Koichi Isayama, et al.
Pageof 20

Showing results (91-100 of 195) with videos related to

Sort By:
Pageof 20
Mitochondrion|July 22, 2019
A mitochondrial delivery system using liposome-based nanocarriers that target myoblast cellsTakashi Katayama, Shintaro Kinugawa, Shingo Takada, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|May 27, 2024
Esaxerenone: blood pressure reduction and cardiorenal protection without reflex sympathetic activation in salt-loaded stroke-prone spontaneously hypertensive ratsShota Ikeda, Keisuke Shinohara, Soichiro Kashihara, et al.
International Journal of Cardiology|June 15, 2010
Hyperuricemia predicts adverse outcomes in patients with heart failureSanae Hamaguchi, Tomoo Furumoto, Miyuki Tsuchihashi-Makaya, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|July 15, 2011
Lower aerobic capacity was associated with abnormal intramuscular energetics in patients with metabolic syndromeTakashi Yokota, Shintaro Kinugawa, Koichi Okita, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|December 5, 2009
Discharge use of angiotensin receptor blockers provides comparable effects with angiotensin-converting enzyme inhibitors on outcomes in patients hospitalized for heart failureMiyuki Tsuchihashi-Makaya, Tomoo Furumoto, Shintaro Kinugawa, et al.
American Heart Journal|December 15, 2010
Spironolactone use at discharge was associated with improved survival in hospitalized patients with systolic heart failureSanae Hamaguchi, Shintaro Kinugawa, Miyuki Tsuchihashi-Makaya, et al.
International Journal of Cardiology|April 19, 2011
Sex differences with respect to clinical characteristics, treatment, and long-term outcomes in patients with heart failureMiyuki Tsuchihashi-Makaya, Sanae Hamaguchi, Shintaro Kinugawa, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|November 10, 2010
Body mass index is an independent predictor of long-term outcomes in patients hospitalized with heart failure in JapanSanae Hamaguchi, Miyuki Tsuchihashi-Makaya, Shintaro Kinugawa, et al.
Life Sciences|April 3, 2020
Branched-chain amino acid supplementation ameliorates angiotensin II-induced skeletal muscle atrophyKatsuma Yamanashi, Shintaro Kinugawa, Arata Fukushima, et al.
Inflammation and Regeneration|March 10, 2026
Amphiregulin attenuates sepsis-induced myocardial dysfunction by maintaining the localization of connexin43Man Chen, Shinnosuke Takamori, Koichi Isayama, et al.
Pageof 20